However, we confirmed the significant reduction of KLC1 in both AD and AD-DS samples with PMIs ≤6 h—i.e., under conditions in which there was no significant postmortem degradation of KLC1 in either AD or AD-DS samples. This evidence concerns the gene KLC1 and Dravet syndrome.